| Table 1. Demographics of recruited patients. | ||||||
| Normozoospermic | Asthenozoospermic | |||||
|---|---|---|---|---|---|---|
| Control | R 100 nM | R 1µM | Control | R 100 nM | R 1µM | |
| VCL (μm/s) | 114.79±2.38a | 121.42±1.98b | 124.55±2.04b | 81.25±2.17a | 94.33±1.76b | 89.54±2.41b |
| VSL (μm/s) | 58.13±2.19a | 64.71±1.83b | 67.34±1.45b | 37.94±2.23a | 48.56±2.11b | 45.63±1.85b |
| VAP (μm/s) | 59.43±1.77a | 65.95±2.14b | 66.74±1.68b | 38.40±2.3a | 49.78±2.51b | 46.58±2.15b |
| LIN % | 50.61±2.44a | 53.27±2.31a | 54.08±1.53a | 46.61±2.06a | 51.44±2.22b | 50.96±1.53a |
| STR % | 96.81±1.56a | 97.11±2.05a | 98.76±2.37a | 97.42±2.51a | 97.51. ±1.86a | 97.22±2.15a |
| WOB % | 51.65±2.11a | 54.21±1.94a | 53.49±2.42a | 47.21±2.23a | 52.14±1.72a | 50.92. ±1.24a |
| ALH (μm/s) | 2.26±1.58a | 2.56±2.02a | 2.97±2.14b | 2.05±1.72a | 2.34±2.23a | 2.12±2.36a |
| BCF (Hz) | 11.15±1.83a | 12.57±2.31a | 12.74±1.66b | 8.55±1.35a | 8.72±2.46a | 8.40±1.87a |
| Hyperactive % | 1.2±0.69a | 12.75±0.50b | 16.40±0.36b | 1.1±0.53a | 11.16±1.74b | 6.20±1.23b |
Data are expressed as means ± SEM.
a/b Values within columns with different superscripts are significant differences (ANOVA, p<0.05).
Control: without repaglinide; R 100 nM: 100 nM concentration of repaglinide; R 1µM: 1µM concentration of repaglinide.
VCL: Curvilinear velocity, VSL: Straight-line velocity, VAP: Average path velocity, LIN: Linearity, STR Straightness, Wob: Wobble, ALH: Amplitude of lateral head displacement, BCF: beat/cross-frequency.